Vinay Agrawal, Director, CEO Of Brokerage Firm 'Angel Broking', Dies
Vinay Agrawal, Chief Executive Officer (CEO) and Director of leading stockbroking firm, Angel Broking, died on Saturday, April 17. According to a regulatory filing by the firm to the BSE on Saturday, Mr. Vinay Agrawal, whole‐time Director and Chief Executive Officer of Angel Broking died on Saturday. Mr Vinay Agrawal joined the stockbroking firm in 2000 and is a chartered accountant by profession. He had more than 15 years of experience in the banking, financial services and insurance (BFSI) sector and has covered multiple facets in the brokering industry such as business development, finance and operations, e-broking, and product development.
Mr Agrawal played an instrumental role in setting up the equity derivatives business segment, which contributes over 50 per cent to the total revenue. He also played a major role in setting up the online trading platform for clients in 2004.
Recently, the company also announced that it will consider declaring an interim dividend for fiscal 2020-21. This will be the third interim dividend for the firm for the financial year 2020-21.
According to the statement, a meeting of the board of directors of the company is scheduled to be held on Thursday, April 22, 2021, to consider declaring a third interim dividend for the financial year 2021-21. The company informed Bombay Stock Exchnage that it has fixed April 30, 2021, as the record date for the payment of the third interim dividend, if any.
Angel broking was incorporated in 1987 and is headquartered in Mumbai. The company offers services such as online stock broking, commodity trading, investment advisory services, depository services.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.